← Leaderboards
Kishore Guda
Case Western Reserve University
$5,264,331
Attributed
$7,847,300
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,312,042 · 6
By mechanism
U54$7,349,189 · 2
P01$6,603,958 · 1
U01$3,874,453 · 1
R01$1,801,967 · 1
K08$682,475 · 1
Top collaborators
- Sanford D Markowitz10 shared
- Amitabh Chak8 shared
- William M Grady6 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Hasan Mukhtar$12,132,209
- Amitabh Chak$17,077,792
- Sanjay Gupta$6,255,407
- Sanford D Markowitz$49,710,196
- John S Witte$28,734,737
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenesMolecularPathway InteractionsBaseBarrett EsophagusMolecular MarkerPredispositionBiological MarkersEsophageal AdenocarcinomaMortalitySamplingPhenotypeEsophagusIncidenceColon CarcinomaMucous MembraneColonic NeoplasmsColonDysplasiaMutationPlayDetectionPrevent
Grant awards (29)
Pathways of Injury and Repair in Barrett's Carcinogenesis$2,223,121
P01 · FY2025 · CA
Pathways of Injury and Repair in Barrett's Carcinogenesis$2,111,965
P01 · FY2024 · CA
Pathways of Injury and Repair in Barrett's Carcinogenesis$2,268,872
P01 · FY2023 · CA
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma$504,836
U54 · FY2022 · CA
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma$1,290,333
U54 · FY2021 · CA
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$407,598
U01 · FY2021 · CA
Project 3 - Long Intergenic Non-Coding RNAs in the Malignant Progression of Barrett's Esophagus$289,800
U54 · FY2021 · CA · contact PI
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma$1,289,211
U54 · FY2020 · CA
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$757,530
U01 · FY2020 · CA
EPHA6 as a novel candidate driver gene in colon cancer$362,569
R01 · FY2020 · CA · contact PI
Project 3 - Long Intergenic Non-Coding RNAs in the Malignant Progression of Barrett's Esophagus$289,499
U54 · FY2020 · CA · contact PI
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma$1,492,810
U54 · FY2019 · CA
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$788,470
U01 · FY2019 · CA
EPHA6 as a novel candidate driver gene in colon cancer$351,691
R01 · FY2019 · CA · contact PI
Project 3 - Long Intergenic Non-Coding RNAs in the Malignant Progression of Barrett's Esophagus$331,725
U54 · FY2019 · CA · contact PI
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma$1,283,594
U54 · FY2018 · CA
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$706,863
U01 · FY2018 · CA
EPHA6 as a novel candidate driver gene in colon cancer$362,569
R01 · FY2018 · CA · contact PI
Project 3 - Long Intergenic Non-Coding RNAs in the Malignant Progression of Barrett's Esophagus$289,284
U54 · FY2018 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$596,898
U01 · FY2017 · CA
EPHA6 as a novel candidate driver gene in colon cancer$362,569
R01 · FY2017 · CA · contact PI
Project 3 - Long Intergenic Non-Coding RNAs in the Malignant Progression of Barrett's Esophagus$288,097
U54 · FY2017 · CA · contact PI
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus$617,094
U01 · FY2016 · CA
EPHA6 as a novel candidate driver gene in colon cancer$362,569
R01 · FY2016 · CA · contact PI
Novel O-glycosylation Gene Mutations in Colon Cancer$137,105
K08 · FY2014 · CA · contact PI
Novel O-glycosylation Gene Mutations in Colon Cancer$137,105
K08 · FY2013 · CA · contact PI
Novel O-glycosylation Gene Mutations in Colon Cancer$137,105
K08 · FY2012 · CA · contact PI
Novel O-glycosylation Gene Mutations in Colon Cancer$137,105
K08 · FY2011 · CA · contact PI
Novel O-glycosylation Gene Mutations in Colon Cancer$134,055
K08 · FY2010 · CA · contact PI